Benefit of early versus deferred antiretroviral therapy on progression of liver fibrosis among people with HIV in the START randomized trial.
- Submitting institution
-
University College London
- Unit of assessment
- 2 - Public Health, Health Services and Primary Care
- Output identifier
- 5570
- Type
- D - Journal article
- DOI
-
10.1002/hep.30296
- Title of journal
- Hepatology
- Article number
- -
- First page
- 1135
- Volume
- 69
- Issue
- 3
- ISSN
- 1527-3350
- Open access status
- Compliant
- Month of publication
- February
- Year of publication
- 2019
- URL
-
-
- Supplementary information
-
https://aasldpubs.onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1002%2Fhep.30296&file=hep30296-sup-0001-TableS1-S6.pdf
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
14
- Research group(s)
-
-
- Citation count
- 2
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to: A (ii) the organisation of the conduct of the study; A (iii) carrying out the study; A (iv) analysis and interpretation of study data; B (i) The author helped draft the output;
- Non-English
- No
- English abstract
- -
